Fingerprint
Dive into the research topics of 'Placebo-controlled study of the D4/5-HT(2A) antagonist fananserin in the treatment of schizophrenia'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Placebo-controlled study of the D4/5-HT(2A) antagonist fananserin in the treatment of schizophrenia
Philippe Truffinet, Carol A. Tamminga, Louis F. Fabre, Herbert Y. Meltzer, Marie Emmanuelle Rivière, Catherine Papillon-Downey
Research output: Contribution to journal › Article › peer-review
101
Scopus
citations